Addressing The Challenges Of Residual Host Cell DNA Contamination
By Marwan Alsarraj

With a growing number of exciting advancements in the cell and gene therapy sector, the challenges when manufacturing therapeutics of this type reliably is becoming ever more apparent. One persistent problem is residual host cell DNA contamination.
Droplet Digital™ PCR (ddPCR™) technology offers absolute quantification, eliminating the need for standard curves. It can provide the sensitive, specific, reproducible results needed to meet regulatory standards with confidence. Explore why purification is so important, the limits of common molecular methods, and how ddPCR™ could form the future of molecular detection.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.